Source: Investing.com ↗

Oppenheimer raises Pharvaris stock price target on trial results

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

BTC/USDT

$65,208.84

-5.00%

USDC/USDT

$1.00

-0.00%

ETH/USDT

$1,819.52

-5.56%

SOL/USDT

$72.39

-8.85%

USD1/USDT

$0.9988

-0.03%